Pam3CSK4 – a TLR1/2 Agonist

Pam3CSK4 – a TLR1/2 Agonist

Toll-like receptor 1 (TLR1) recognises pathogen-associated molecular patterns (PAMPS) with a specificity for Gram-positive bacteria. TLR1 recognises peptidoglycan and triacyl lipoproteins in concert with TLR2.

Pam3CSK4 is a selective agonist to the TLR1/TLR2 heterodimer complex. It is a cell permeable and water soluble synthetic tripalmitoylated lipopeptide that activates the acylated amino terminus of bacterial lipoproteins. Pam3CSK4 activates monocytes and macrophages, is a potent and effective immune adjuvant, and is also a potent activator of the pro-inflammatory transcription factor NF-κB.

Product Information

Pam3Cys-Ser-(Lys)4. 3HCl (2mg)

Caltag Medsystems is the distributor of Adipogen Life Sciences products in the UK and Ireland. If you have any questions about these products, please contact us.

To view the full list of references related to Pam3CSK4, please click here.

References

Buwitt-Beckmann et al (2005). TLR1- and TLR6-independent Recognition of Bacterial Lipopeptides. The Journal of Biological Chemistry 281 (14): 9049 –9057

Buwitt-Beckmann et al (2005). Lipopeptide structure determines TLR2 dependent cell activation level. The FEBS Journal 274 (24): 6354-6364

Muèller et al (2000). Immunostimulation by the synthetic lipopeptide P3CSK4: TLR4-independent activation of the ERK1/2 signal transduction pathway in macrophages. Immunology 103: 49-60

Erhard et al (2000). Adjuvant Effects of Various Lipopeptides and Interferon-γ on the Humoral Immune Response of Chickens. Poultry Science 79: 1264–1270

Aliprantis et al (1999). Cell activation and apoptosis by bacterial lipoproteins through toll-like receptor-2. Science 285 (5428): 736-9

Pam3CSK4 – a TLR1/2 Agonist

Contact us